Biomater. Sci., 2026, Accepted Manuscript
DOI: 10.1039/D5BM01792K, Paper
DOI: 10.1039/D5BM01792K, Paper
Open Access
  This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Yu Wang, Kathrin Kostka-Wirtz, Nils Bartelsen, Kateryna Loza, Christoph Weingärtner, Philipp Arnold, Dominik Damm, Klaus Überla, Matthias Epple, Vladimir Temchura
The development of a safe, effective, and accessible human immunodeficiency virus 1 (HIV-1) vaccine remains a global priority, and nanoparticles (NPs) have emerged as a promising platform for vaccine delivery....
The content of this RSS Feed (c) The Royal Society of Chemistry
The development of a safe, effective, and accessible human immunodeficiency virus 1 (HIV-1) vaccine remains a global priority, and nanoparticles (NPs) have emerged as a promising platform for vaccine delivery....
The content of this RSS Feed (c) The Royal Society of Chemistry
.png)










English (US)